Milan Flekač
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Clinical Biochemistry top 5%
- Paraoxonase enzyme and polymorphisms
- Advanced Glycation End Products research
Papers in
-
- Diabetes Management and Research 7
- Diabetes Treatment and Management 4
-
- Metabolism, Diabetes, and Cancer 4
- Co-authors
- J Škrha (7 shared papers)Z Lacinová (2 shared papers)J Hilgertová (2 shared papers)Martin Prázný (7 shared papers)Jan Šoupal (6 shared papers)Tomáš Pelcl (4 shared papers)Martin Matoulek (2 shared papers)Š Svačina (2 shared papers)
- Journals
- Physiological Research (2 papers)Diabetes Research and Clinical Practice (2 papers)Diabetes Technology & Therapeutics (1 paper)Diabetes Care (1 paper)Diabetes (1 paper)
- Partner nations
- CzechiaUnited StatesUnited Kingdom
In The Last Decade
Milan Flekač
13 papers receiving 541 citations
Peers
Comparison fields: 5 of 70
- Endocrinology, Diabetes and Metabolism 299
- Clinical Biochemistry 109
- Genetics 107
- Sensory Systems 18
- Surgery 137
Countries citing papers authored by Milan Flekač
This map shows the geographic impact of Milan Flekač's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milan Flekač with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milan Flekač more than expected).
Fields of papers citing papers by Milan Flekač
This network shows the impact of papers produced by Milan Flekač. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milan Flekač. The network helps show where Milan Flekač may publish in the future.
Co-authors
The 25 scholars most cited alongside Milan Flekač, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 176 | |
| 2 | 2008 | 133 | |
| 3 | 2016 | 95 | |
| 4 | 2008 | 80 | |
| 5 | 2008 | 35 | |
| 6 | 2021 | 20 | |
| 7 | 2014 | 17 | |
| 8 | 2020 | 10 | |
| 9 | 2020 | 6 | |
| 10 | 2018 | 2 | |
| 11 | 2019 | 2 | |
| 12 | 2020 | 1 | |
| 13 | [Clinical efficacy and safety of basal insulin analogue glargine in patients with type 2 diabetes mellitus]. | 2017 | 1 |
| 14 | 2016 | 0 | |
| 15 | 2025 | 0 |
About Milan Flekač
Milan Flekač is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Clinical Biochemistry, Cardiology and Cardiovascular Medicine and Surgery, having authored 15 papers that have together received 578 indexed citations. Recurring topics across this work include Diabetes Management and Research (7 papers), Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Cardiovascular Health and Disease Prevention (2 papers), Advanced Glycation End Products research (2 papers), Cardiovascular and exercise physiology (1 paper), Diabetes and associated disorders (1 paper) and Biochemical Acid Research Studies (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (299 citations), Clinical Biochemistry (109 citations), Genetics (107 citations), Sensory Systems (18 citations) and Surgery (137 citations). Milan Flekač has collaborated with scholars based in Czechia, United States and United Kingdom. Frequent co-authors include J Škrha, Z Lacinová, J Hilgertová, Martin Prázný, Jan Šoupal, Tomáš Pelcl, Martin Matoulek, Š Svačina, Lenka Petruželková and J Škrha. Their work appears in journals such as Physiological Research, Diabetes Research and Clinical Practice, Diabetes Technology & Therapeutics, Diabetes Care and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.